David Good

David Good is an experienced professional in business development and scientific leadership, currently serving as Senior Director of Business Development at Aliri since March 2024 and as an Advisory Board Member at Immuto Scientific since December 2021. Previously, David held the position of Director of Business Development at BioAgilytix from January 2023 to March 2024, focusing on client expansion and new sponsor onboarding. David's career also includes significant roles such as Senior Pricing Manager at Labcorp Drug Development, where global pricing strategy support was provided, and scientific leadership roles at Covance, overseeing mass spectrometry projects for large biomolecules and small molecules. David's educational background includes post-doctoral studies in Oncology and Cancer Biology at the University of Wisconsin-Madison and Bioanalytical Chemistry at Karolinska Institutet, along with a Ph.D. in Analytical Chemistry from the University of Wisconsin-Madison.